184 related articles for article (PubMed ID: 28382154)
1. Analysis of origin and protein-protein interaction maps suggests distinct oncogenic role of nuclear EGFR during cancer evolution.
Sharip A; Abdukhakimova D; Wang X; Kim A; Kim Y; Sharip A; Orakov A; Miao L; Sun Q; Chen Y; Chen Z; Xie Y
J Cancer; 2017; 8(5):903-912. PubMed ID: 28382154
[TBL] [Abstract][Full Text] [Related]
2. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
[TBL] [Abstract][Full Text] [Related]
3. Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer.
Brand TM; Iida M; Dunn EF; Luthar N; Kostopoulos KT; Corrigan KL; Wleklinski MJ; Yang D; Wisinski KB; Salgia R; Wheeler DL
Mol Cancer Ther; 2014 May; 13(5):1356-68. PubMed ID: 24634415
[TBL] [Abstract][Full Text] [Related]
4. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
[TBL] [Abstract][Full Text] [Related]
5. RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor.
Brand TM; Iida M; Corrigan KL; Braverman CM; Coan JP; Flanigan BG; Stein AP; Salgia R; Rolff J; Kimple RJ; Wheeler DL
Sci Signal; 2017 Jan; 10(460):. PubMed ID: 28049763
[TBL] [Abstract][Full Text] [Related]
6. The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer.
Mandel A; Larsson P; Sarwar M; Semenas J; Syed Khaja AS; Persson JL
Mol Med; 2018 Jun; 24(1):34. PubMed ID: 30134822
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel tripartite nuclear localization sequence in the EGFR family.
Hsu SC; Hung MC
J Biol Chem; 2007 Apr; 282(14):10432-40. PubMed ID: 17283074
[TBL] [Abstract][Full Text] [Related]
8. Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer.
Traynor AM; Weigel TL; Oettel KR; Yang DT; Zhang C; Kim K; Salgia R; Iida M; Brand TM; Hoang T; Campbell TC; Hernan HR; Wheeler DL
Lung Cancer; 2013 Jul; 81(1):138-41. PubMed ID: 23628526
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.
Chan SC; Li Y; Dehm SM
J Biol Chem; 2012 Jun; 287(23):19736-49. PubMed ID: 22532567
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.
Wang JL; Fang CL; Tzeng YT; Hsu HL; Lin SE; Yu MC; Bai KJ; Wang LS; Liu HE
J Biomed Sci; 2018 Jun; 25(1):53. PubMed ID: 29950164
[TBL] [Abstract][Full Text] [Related]
11. The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer.
Kuo HY; Chen YC; Chang HY; Jeng JC; Lin EH; Pan CM; Chang YW; Wang ML; Chou YT; Shih HM; Wu CW
Carcinogenesis; 2013 Aug; 34(8):1708-16. PubMed ID: 23563092
[TBL] [Abstract][Full Text] [Related]
12. Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.
Thamilselvan V; Menon M; Stein GS; Valeriote F; Thamilselvan S
J Cell Biochem; 2017 Dec; 118(12):4331-4340. PubMed ID: 28430389
[TBL] [Abstract][Full Text] [Related]
13. Nuclear EGFR Expression Is Associated With Poor Survival in Laryngeal Carcinoma.
Marijić B; Braut T; Babarović E; Krstulja M; Maržić D; Avirović M; Kujundžić M; Hadžisejdić I
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):576-584. PubMed ID: 33758141
[TBL] [Abstract][Full Text] [Related]
14. Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation.
Kim JH; Choi HS; Lee DS
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884765
[TBL] [Abstract][Full Text] [Related]
15. DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.
Lin HP; Ho HM; Chang CW; Yeh SD; Su YW; Tan TH; Lin WJ
FASEB J; 2019 Dec; 33(12):14653-14667. PubMed ID: 31693867
[TBL] [Abstract][Full Text] [Related]
16. EphB4 localises to the nucleus of prostate cancer cells.
Mertens-Walker I; Lisle JE; Nyberg WA; Stephens CR; Burke L; Rutkowski R; Herington AC; Stephenson SA
Exp Cell Res; 2015 Apr; 333(1):105-15. PubMed ID: 25724901
[TBL] [Abstract][Full Text] [Related]
17. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
[TBL] [Abstract][Full Text] [Related]
18. Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Nie L; Wang YN; Hsu JM; Hou J; Chu YY; Chan LC; Huo L; Wei Y; Deng R; Tang J; Hsu YH; Ko HW; Lim SO; Huang K; Chen MK; Chiu TJ; Cheng CC; Fang YF; Li CW; Goverdhan A; Wu HJ; Lee CC; Wang WL; Hsu J; Chiao P; Wang SC; Hung MC
Am J Cancer Res; 2023; 13(4):1209-1239. PubMed ID: 37168336
[TBL] [Abstract][Full Text] [Related]
19. The androgen receptor associates with the epidermal growth factor receptor in androgen-sensitive prostate cancer cells.
Bonaccorsi L; Muratori M; Carloni V; Marchiani S; Formigli L; Forti G; Baldi E
Steroids; 2004 Aug; 69(8-9):549-52. PubMed ID: 15288768
[TBL] [Abstract][Full Text] [Related]
20. Nuclear transport signals control cellular localization and function of androgen receptor cofactor p44/WDR77.
Gu Z; Zhou L; Gao S; Wang Z
PLoS One; 2011; 6(7):e22395. PubMed ID: 21789256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
